Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Dana Swartzberg Wollins"'
Autor:
Jason C. Gallagher, Yngve Falck-Ytter, William J. Muller, Shmuel Shoham, Adarsh Bhimraj, John C. O’Horo, Lindsey R. Baden, Dana Swartzberg Wollins, Rajesh T. Gandhi, Amy Hirsch Shumaker, Vincent C.C. Cheng, Valery Lavergne, Kathryn M. Edwards, Rebecca L. Morgan
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Given the urgent need for treatments during the coronavirus disease 2019 pandemic, the US Food and Drug Administration issued emergency use authorizations (EUAs) for multiple therapies. In several instances, however, these EUAs were issued before suf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba1ba8f67b0dc8904ccac54ddedf6342
https://doi.org/10.1093/cid/ciab880
https://doi.org/10.1093/cid/ciab880
Autor:
Amy Hirsch Shumaker, Rajesh T. Gandhi, Kathryn M. Edwards, Vincent C.C. Cheng, Rebecca L. Morgan, Jason C. Gallagher, Lindsey R. Baden, William J. Muller, Adarsh Bhimraj, Dana Swartzberg Wollins, Yngve Falck-Ytter, John C. O’Horo, Shmuel Shoham
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Despite the challenges of the pandemic, there has been substantial progress with coronavirus disease 2019 (COVID-19) therapies. Pivotal COVID-19 trials like SOLIDARITY, RECOVERY, and ACCT-1 were rapidly conducted and data disseminated to support effe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74651c6a4556348567ccf4e1492a0aa8
https://doi.org/10.1093/cid/ciab882
https://doi.org/10.1093/cid/ciab882
Autor:
Ravina Kullar, Sarah H. Sutton, Susan C Bleasdale, Ellie J. C. Goldstein, Dana Swartzberg Wollins, Snezana Naumovski, Jerod Nagel, Cheryl Smith, James E. Leggett, Chris Busky
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 71(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ce198d42ef8f2ad78aff4adaab488f8
https://pubmed.ncbi.nlm.nih.gov/31544205
https://pubmed.ncbi.nlm.nih.gov/31544205
Autor:
Lu KH; Karen H. Lu, Molly Daniels, and Cathy Burke, MD Anderson Cancer Center, Houston; Linda Robinson, Simmons Comprehensive Cancer Center, Dallas, TX; Marie E. Wood, University of Vermont, Burlington, VT; James Ford, Stanford University Medical Center, Stanford, CA; Noah D. Kauff, Memorial Sloan-Kettering Cancer Center, New York, NY; Wendy Kohlmann, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Noralane M. Lindor, Mayo Clinic, Scottsdale, AZ; Therese M. Mulvey, Southcoast Centers for Cancer Care, Fall River; Sapna Syngal, Dana-Farber Cancer Institute, Brigham and Women's Hospital; Kevin S. Hughes, Avon Comprehensive Breast Evaluation Center, Massachusetts General Hospital, Boston, MA; Wendy Rubinstein, National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD; Elena M. Stoffel, University of Michigan, Ann Arbor, MI; Carrie Snyder, Creighton University, Omaha, NE; and Janette K. Merrill and Dana Swartzberg Wollins, American Society of Clinical Oncology, Alexandria, VA., Wood ME, Daniels M, Burke C, Ford J, Kauff ND, Kohlmann W, Lindor NM, Mulvey TM, Robinson L, Rubinstein WS, Stoffel EM, Snyder C, Syngal S, Merrill JK, Wollins DS, Hughes KS
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2014 Mar 10; Vol. 32 (8), pp. 833-40. Date of Electronic Publication: 2014 Feb 03.